These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35142836)

  • 1. Estimated Costs of Severe Adverse Drug Reactions Resulting in Hospitalization in the Veterans Health Administration.
    Aspinall SL; Vu M; Moore V; Jiang R; Au A; Bounthavong M; Glassman PA
    JAMA Netw Open; 2022 Feb; 5(2):e2147909. PubMed ID: 35142836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost implications of adverse drug event-related emergency department visits - a multicenter study in South Korea.
    Lee MS; Lee JY; Kang MG; Jung JW; Park HK; Park HK; Kim SH; Lee EK
    Expert Rev Pharmacoecon Outcomes Res; 2020 Feb; 20(1):139-146. PubMed ID: 31012333
    [No Abstract]   [Full Text] [Related]  

  • 3. The Association Between Neighborhood Socioeconomic and Housing Characteristics with Hospitalization: Results of a National Study of Veterans.
    Hatef E; Kharrazi H; Nelson K; Sylling P; Ma X; Lasser EC; Searle KM; Predmore Z; Batten AJ; Curtis I; Fihn S; Weiner JP
    J Am Board Fam Med; 2019; 32(6):890-903. PubMed ID: 31704758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.
    Kabadi SM; Near A; Wada K; Burudpakdee C
    Cancer Med; 2019 Dec; 8(17):7174-7185. PubMed ID: 31595715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Marginal Costs of Adverse Drug Events Associated With Exposures to Anticoagulants and Hypoglycemic Agents During Hospitalization.
    Spector WD; Limcangco R; Furukawa MF; Encinosa WE
    Med Care; 2017 Sep; 55(9):856-863. PubMed ID: 28742544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimorbidity and healthcare utilisation among high-cost patients in the US Veterans Affairs Health Care System.
    Zulman DM; Pal Chee C; Wagner TH; Yoon J; Cohen DM; Holmes TH; Ritchie C; Asch SM
    BMJ Open; 2015 Apr; 5(4):e007771. PubMed ID: 25882486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
    Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
    BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.
    Wu C; Bell CM; Wodchis WP
    Drug Saf; 2012 Sep; 35(9):769-81. PubMed ID: 22823502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Adverse Drug Events with Hospitalization Outcomes and Costs in Older Adults in the USA using the Nationwide Readmissions Database.
    Riaz M; Brown JD
    Pharmaceut Med; 2019 Aug; 33(4):321-329. PubMed ID: 31933184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States.
    Korsnes JS; Goodwin BB; Murray M; Candrilli SD
    Ann Pharmacother; 2016 Dec; 50(12):989-1000. PubMed ID: 27439947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database.
    Poudel DR; Acharya P; Ghimire S; Dhital R; Bharati R
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):635-641. PubMed ID: 28233421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial.
    O'Connor MN; O'Sullivan D; Gallagher PF; Eustace J; Byrne S; O'Mahony D
    J Am Geriatr Soc; 2016 Aug; 64(8):1558-66. PubMed ID: 27365262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direct costs of drug-induced skin reactions.
    Kiepurska N; Paluchowska E; Owczarek W; Szkultecka-Dębek M; Jahnz-Różyk K
    Ann Agric Environ Med; 2017 May; 24(2):190-193. PubMed ID: 28664692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness of drugs modifications for inpatients hospitalised in acute care geriatric units].
    Lachamp M; Pauly V; Sambuc R; Thirion X; Potard I; Molines C; Retornaz F
    Rev Med Interne; 2012 Sep; 33(9):482-90. PubMed ID: 22726238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Adverse Reactions Caused by Potentially Inappropriate Prescriptions and Related Medical Costs That Are Avoidable Using the Beers Criteria: The Japanese Version and Guidelines for Medical Treatment and Its Safety in the Elderly 2015.
    Tachi T; Kanematsu Y; Aoyama S; Katsuno H; Otsubo M; Ueno A; Sugita I; Yoshida A; Noguchi Y; Yasuda M; Mizui T; Goto C; Teramachi H
    Biol Pharm Bull; 2019; 42(5):712-720. PubMed ID: 31061313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults.
    Chan SL; Ng HY; Sung C; Chan A; Winther MD; Brunham LR; Wee HL
    Pharmacogenomics J; 2019 Aug; 19(4):401-410. PubMed ID: 30250149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria.
    Oshikoya KA; Chukwura H; Njokanma OF; Senbanjo IO; Ojo I
    Sao Paulo Med J; 2011 May; 129(3):153-64. PubMed ID: 21755250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect drug-related costs.
    Moore N; Briffaut C; Noblet C; Normand CA; Thuillez C
    Lancet; 1995 Mar; 345(8949):588-9. PubMed ID: 7776802
    [No Abstract]   [Full Text] [Related]  

  • 19. The economic burden of preventable adverse drug reactions: a systematic review of observational studies.
    Formica D; Sultana J; Cutroneo PM; Lucchesi S; Angelica R; Crisafulli S; Ingrasciotta Y; Salvo F; Spina E; Trifirò G
    Expert Opin Drug Saf; 2018 Jul; 17(7):681-695. PubMed ID: 29952667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and length of stay of drug-related hospital admissions in cancer patients.
    Ko Y; Gwee YS; Huang YC; Chiang J; Chan A
    Clin Ther; 2014 Apr; 36(4):588-92. PubMed ID: 24636525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.